VectivBio Holding AG Ordinary Shares (VECT)

VECT was delisted on the 7th of July, 2023.

• Market cap: $1.06B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: VectivBio Holding AG is a clinical stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for which there is a significant unmet medical need. The product candidate is apraglutide, which is a next generation, long-acting synthetic peptide analog of glucagon-like peptide-2, or GLP-2, which is developed as a differentiated therapeutic for a range of rare GI diseases, with an initial focus on short bowel syndrome.

Employees: 42